Sarah Westall: Massive International HCQ Study Shows Substantially More Deaths in Countries Not Using HCQ Early

Source: Sarah Westall

Massive international study looks at 70 Hydroxychloroquine (HCQ) studies of which 42 were peer reviewed. The results showed that countries with early use of HCQ (Costa Rica, Israel, India, Russia, Turkey, Algeria, Morocco, Indonesia, Ukraine, Greece, Cuba) had significantly less deaths than those countries that restricted widespread HCQ use (Mexico, USA, U.K, Sweden, Ireland, France, Netherlands, France). Study involves the populations of 2 billion people. 

The glaringly obvious question is how many lives would have been saved if our CDC, health “experts”, and mass media, did not lie about the dangers of this live saving drug? 

Dr. Oskoui appears on the The Ingraham Angle with Laura Ingraham to explain and discuss this international study. He states there needs to be consequences for the blatant disregard for medicines that save lives. Here is his specific statement:

Dr. Oskoui: It’s really devastating to Dr. Fauci, Dr. Hahn, Dr. Redfield and their performance.  I think not only should they be embarrassed but I think they really need to be held to account…  Physicians have a fiduciary responsibility to act in the best interests of their patients.




Related:

Gateway Pundit – HUGE DEVELOPMENT: 51 Global Studies Find HCQ Effective in Treating COVID-19 -16 Find HCQ NOT Effective -But 10 of Those Are Late Treatment Studies! –

Hydroxychloroquine: Evidence suggests it is relatively safe

Global Research: Media Sabotage of Hydroxychloroquine Use for COVID-19; Doctors Worldwide Protest the Disaster

Bombshell: Media disinformation proven false as Henry Ford Health study finds Hydroxychloroquine lowers COVID-19 death rate.

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »

The Chloroquine Wars Part XIV – How to Rig Research: Surgisphere Part I

It was in these very moments in late May when public health officials lost all credibility—a credibility that cannot be restored without major changes taking place. Despite most evidence pointing to a likelihood of HCQ efficacy, they made their call on the back of data supposedly tucked away in a database that nobody had verified, declared it definitive, then swiftly pushed for policy changes around the world.

Read More »